32 results on '"Vanden Driessche K"'
Search Results
2. Additional file 1 of Central nervous system manifestations of LRBA deficiency: case report of two siblings and literature review
- Author
-
Mangodt, T. C., Vanden Driessche, K., Norga, K. K., Moes, N., De Bruyne, M., Haerynck, F., Bordon, V., Jansen, A. C., and Jonckheere, A. I.
- Abstract
Additional file 1: Supplemental figure S1. Diffusion-weighted imaging (DWI; a and b) demonstrating bilateral parieto-occipital cortical diffusion restriction. Apparent diffusion coefficient (ADC; c and d) map confirming diffusion restriction in these regions. Images in conjunction with those in Fig. 2 compatible with PRES. Images from patient P1.
- Published
- 2023
- Full Text
- View/download PDF
3. Additional file 4 of Central nervous system manifestations of LRBA deficiency: case report of two siblings and literature review
- Author
-
Mangodt, T. C., Vanden Driessche, K., Norga, K. K., Moes, N., De Bruyne, M., Haerynck, F., Bordon, V., Jansen, A. C., and Jonckheere, A. I.
- Abstract
Additional file 4: Supplemental figure S4. DWI images (a and b) demonstrating bilateral fronto-parieto-occipital cortical diffusion restriction. ADC map (c and d) confirming diffusion restriction in the cortex of these regions. Images in conjunction with those in Fig. 6 compatible with PRES. Images from patient P2.
- Published
- 2023
- Full Text
- View/download PDF
4. Additional file 2 of Central nervous system manifestations of LRBA deficiency: case report of two siblings and literature review
- Author
-
Mangodt, T. C., Vanden Driessche, K., Norga, K. K., Moes, N., De Bruyne, M., Haerynck, F., Bordon, V., Jansen, A. C., and Jonckheere, A. I.
- Abstract
Additional file 2: Supplemental figure S2. T2-FLAIR hyperintense contrast-enhanced lesions occurring widely spread in the supratentorial (a, b, c, d) and infratentorial (d) grey matter. Note as well the lesions in the lateral part of the right external globus pallidus (c, full arrow) and the left parahippocampal gyrus (d, dashed arrow). As in Fig. 2 and 3, the arachnoidal cyst in the left temporal region can also be observed (c, dashed arrow). Evolution after 6 months of treatment with abatacept can be seen on the follow-up images depicted with (ii), demonstrating global regression of the lesions and decreased contrast enhancement. Images from patient P1.
- Published
- 2023
- Full Text
- View/download PDF
5. Additional file 3 of Central nervous system manifestations of LRBA deficiency: case report of two siblings and literature review
- Author
-
Mangodt, T. C., Vanden Driessche, K., Norga, K. K., Moes, N., De Bruyne, M., Haerynck, F., Bordon, V., Jansen, A. C., and Jonckheere, A. I.
- Abstract
Additional file 3: Supplemental figure S3. Expansive lesion of the cervical spinal medulla from C3-C4 down to Th1-Th2. On the T1-weighted images (a and b) the patchy superficial contrast enhancement can be seen. Evolution after 6 months of treatment with abatacept can be observed on the follow-up images depicted with (ii), demonstrating reduced extent and decreased contrast enhancement. Images from patient P1.
- Published
- 2023
- Full Text
- View/download PDF
6. Infliximab for Paradoxical Reactions in Pediatric Central Nervous System Tuberculosis
- Author
-
Abo, Y-N, Curtis, N, Osowicki, J, Haeusler, G, Purcell, R, Kadambari, S, De Wachter, M, Vanden Driessche, K, Dekeyzer, S, Coleman, L, Crawford, N, Graham, S, Marais, B, Gwee, A, Abo, Y-N, Curtis, N, Osowicki, J, Haeusler, G, Purcell, R, Kadambari, S, De Wachter, M, Vanden Driessche, K, Dekeyzer, S, Coleman, L, Crawford, N, Graham, S, Marais, B, and Gwee, A
- Abstract
Paradoxical reactions in central nervous system tuberculosis (CNS-TB) are associated with significant morbidity and mortality. We describe 4 HIV-uninfected children treated for CNS-TB with severe paradoxical reactions unresponsive to corticosteroids. All made recovery after treatment with infliximab, highlighting the safety and effectiveness of infliximab for this complication, and need for prospective trials.
- Published
- 2021
7. Impact of HIV on clinical presentation and outcomes of tuberculosis treatment at primary care level [Short communication]
- Author
-
F. Behets, Cassidy Henegar, Martine Tabala, Vanden Driessche K, and Van Rie A
- Subjects
Pulmonary and Respiratory Medicine ,education.field_of_study ,Pediatrics ,medicine.medical_specialty ,Tuberculosis ,business.industry ,Population ,Human immunodeficiency virus (HIV) ,Developing country ,Primary care ,medicine.disease_cause ,medicine.disease ,Pediatric tuberculosis ,Child mortality ,Infectious Diseases ,Case fatality rate ,medicine ,education ,business - Abstract
Little is known on how human immunodeficiency virus (HIV) infection impacts pediatric tuberculosis (TB) in primary care. We compared TB type, HIV care and case fatality rates between 5685 adults and 830 children with TB treated at primary care clinics in Kinshasa, Democratic Republic of Congo. Children represented a substantial burden (13%) of TB, and presented predominantly with difficult to diagnose smear-negative TB and extra-pulmonary TB. The HIV co-infection rate was lower in children than in adults, and fewer children than adults received antiretroviral therapy during anti-tuberculosis treatment. Case fatality was four times higher in HIV-infected than non-infected children. Child-friendly point-of-care TB diagnostics and decentralized pediatric TB-HIV care should receive greater attention.
- Published
- 2013
8. Impact of HIV on clinical presentation and outcomes of tuberculosis treatment at primary care level [Short communication]
- Author
-
Henegar, C., primary, Behets, F., additional, Vanden Driessche, K., additional, Tabala, M., additional, and Van Rie, A., additional
- Published
- 2013
- Full Text
- View/download PDF
9. Outcomes of integrated treatment for tuberculosis and HIV in children at the primary health care level
- Author
-
Patel, M. R., primary, Yotebieng, M., additional, Behets, F., additional, Vanden Driessche, K., additional, Nana, M., additional, and Van Rie, A., additional
- Published
- 2013
- Full Text
- View/download PDF
10. The Cough Cylinder: a tool to study measures against airborne spread of (myco-) bacteria
- Author
-
Vanden Driessche, K., primary, Marais, B. J., additional, Wattenberg, M., additional, Magis-Escurra, C., additional, Reijers, M., additional, Tuinman, I. L., additional, Boeree, M. J., additional, van Soolingen, D., additional, de Groot, R., additional, and Cotton, M. F., additional
- Published
- 2013
- Full Text
- View/download PDF
11. Mortality among tuberculosis patients in the Democratic Republic of Congo
- Author
-
Henegar, C., primary, Behets, F., additional, Vanden Driessche, K., additional, Tabala, M., additional, Bahati, E., additional, Bola, V., additional, and Van Rie, A., additional
- Published
- 2012
- Full Text
- View/download PDF
12. COVID-19 in children and adolescents in Europe: a multinational, multicentre cohort study
- Author
-
Benoît Bernar, Astrid Rojahn, Laura Jones, Elisabeth Schölvinck, Robin Kobbe, Laura Lancella, Delane Shingadia, Fiona Shackley, Lynne McFetridge, Conor Doherty, Cornelius Rau, Nicolaus Schwerk, Oksana Kozdoba, Koen Vanden Driessche, Arnaud G L'Huillier, Jasmin Pfefferle, Srini Bandi, R Song, Andreia Ribeiro, Ivan Solovic, Jonathan P. Glenthoej, Ulrich Heininger, Susana Melendo, Tine Boiy, Uros Krivec, An Bael, Luca Pierantoni, Edda Haberlandt, Miguel Lanaspa, Noémie Wagner, Andrea Lo Vecchio, Francesc Ripoll, Lise Heilmann Jensen, Piero Valentini, Anita Niederer, Roland Berger, Nicole Ritz, Aida M. Gutiérrez-Sánchez, Christelle Christiaens, Franziska Zucol, Katy Fidler, Jolanta Bernatoniene, Anna Starshinova, Volker Strenger, Claus Klingenberg, Ilona Lind, Clare S. Murray, Angela Zacharasiewicz, Ivan Pavic, Amanda Williams, Christina Thir, Vera Chechenyeva, Karsten Kötz, Stephanie Thee, Laura Buchtala, Danilo Buonsenso, Patrick Gavin, Rimvydas Ivaškevicius, Sara Debulpaep, Francesca Ippolita Calò Carducci, Marine Creuven, Beatriz Soto, Srđan Roglić, Lola Falcón, Yvonne Beuvink, Petra Zimmermann, Petra Schelstraete, Lynne Speirs, Daniela S. Kohlfürst, Antoni Noguera-Julian, Mihhail Tistsenko, Steven B. Welch, Hanna Schmid, Anastasios Smyrnaios, Laura Minguell, Andrew Riordan, Michael Buettcher, Angelika Berger, Isabel Carvalho, Daan Van Brusselen, Inga Ivaškeviciene, Matilde Bustillo, Valentina Vilc, Folke Brinkmann, Nina Krajcar, Olaf Neth, Alicia Demirjian, Matthias Bogyi, Ulle Uustalu, Maria Tsolia, Borja Ibanez, Elisabeth Whittaker, Ariane Biebl, Irini Eleftheriou, Burkhard Simma, Petra Prunk, Borbàla Zsigmond, Veronika Osterman, Zoe Oliver, Antoni Soriano-Arandes, Ulrikka Nygaard, Marcello Lanari, Marc Tebruegge, Olga Bilogortseva, Michael Barker, Svetlana Velizarova, Florian Götzinger, Natalia Gabrovska, Begoña Santiago-García, Benhur Şirvan Çetin, Paddy McMaster, Anna Zschocke, Frances Child, Nick Makwana, Mar Santos, Group, ptbnet COVID-19 Study, Gotzinger F., Santiago-Garcia B., Noguera-Julian A., Lanaspa M., Lancella L., Calo Carducci F.I., Gabrovska N., Velizarova S., Prunk P., Osterman V., Krivec U., Lo Vecchio A., Shingadia D., Soriano-Arandes A., Melendo S., Lanari M., Pierantoni L., Wagner N., L'Huillier A.G., Heininger U., Ritz N., Bandi S., Krajcar N., Roglic S., Santos M., Christiaens C., Creuven M., Buonsenso D., Welch S.B., Bogyi M., Brinkmann F., Tebruegge M., Pfefferle J., Zacharasiewicz A., Berger A., Berger R., Strenger V., Kohlfurst D.S., Zschocke A., Bernar B., Simma B., Haberlandt E., Thir C., Biebl A., Vanden Driessche K., Boiy T., Van Brusselen D., Bael A., Debulpaep S., Schelstraete P., Pavic I., Nygaard U., Glenthoej J.P., Heilmann Jensen L., Lind I., Tistsenko M., Uustalu U., Buchtala L., Thee S., Kobbe R., Rau C., Schwerk N., Barker M., Tsolia M., Eleftheriou I., Gavin P., Kozdoba O., Zsigmond B., Valentini P., Ivaskeviciene I., Ivaskevicius R., Vilc V., Scholvinck E., Rojahn A., Smyrnaios A., Klingenberg C., Carvalho I., Ribeiro A., Starshinova A., Solovic I., Falcon L., Neth O., Minguell L., Bustillo M., Gutierrez-Sanchez A.M., Guarch Ibanez B., Ripoll F., Soto B., Kotz K., Zimmermann P., Schmid H., Zucol F., Niederer A., Buettcher M., Cetin B.S., Bilogortseva O., Chechenyeva V., Demirjian A., Shackley F., McFetridge L., Speirs L., Doherty C., Jones L., McMaster P., Murray C., Child F., Beuvink Y., Makwana N., Whittaker E., Williams A., Fidler K., Bernatoniene J., Song R., Oliver Z., Riordan A., Gotzinger, F., Santiago-Garcia, B., Noguera-Julian, A., Lanaspa, M., Lancella, L., Calo Carducci, F. I., Gabrovska, N., Velizarova, S., Prunk, P., Osterman, V., Krivec, U., Lo Vecchio, A., Shingadia, D., Soriano-Arandes, A., Melendo, S., Lanari, M., Pierantoni, L., Wagner, N., L'Huillier, A. G., Heininger, U., Ritz, N., Bandi, S., Krajcar, N., Roglic, S., Santos, M., Christiaens, C., Creuven, M., Buonsenso, D., Welch, S. B., Bogyi, M., Brinkmann, F., Tebruegge, M., Pfefferle, J., Zacharasiewicz, A., Berger, A., Berger, R., Strenger, V., Kohlfurst, D. S., Zschocke, A., Bernar, B., Simma, B., Haberlandt, E., Thir, C., Biebl, A., Vanden Driessche, K., Boiy, T., Van Brusselen, D., Bael, A., Debulpaep, S., Schelstraete, P., Pavic, I., Nygaard, U., Glenthoej, J. P., Heilmann Jensen, L., Lind, I., Tistsenko, M., Uustalu, U., Buchtala, L., Thee, S., Kobbe, R., Rau, C., Schwerk, N., Barker, M., Tsolia, M., Eleftheriou, I., Gavin, P., Kozdoba, O., Zsigmond, B., Valentini, P., Ivaskeviciene, I., Ivaskevicius, R., Vilc, V., Scholvinck, E., Rojahn, A., Smyrnaios, A., Klingenberg, C., Carvalho, I., Ribeiro, A., Starshinova, A., Solovic, I., Falcon, L., Neth, O., Minguell, L., Bustillo, M., Gutierrez-Sanchez, A. M., Guarch Ibanez, B., Ripoll, F., Soto, B., Kotz, K., Zimmermann, P., Schmid, H., Zucol, F., Niederer, A., Buettcher, M., Cetin, B. S., Bilogortseva, O., Chechenyeva, V., Demirjian, A., Shackley, F., Mcfetridge, L., Speirs, L., Doherty, C., Jones, L., Mcmaster, P., Murray, C., Child, F., Beuvink, Y., Makwana, N., Whittaker, E., Williams, A., Fidler, K., Bernatoniene, J., Song, R., Oliver, Z., and Riordan, A.
- Subjects
Male ,Delivery of Health Care / organization & administration ,medicine.medical_treatment ,Coronavirus Infections / therapy ,Coronavirus Infections / epidemiology ,law.invention ,Patient Admission ,0302 clinical medicine ,law ,Risk Factors ,COVID-19 ,children ,Europe ,Developmental and Educational Psychology ,030212 general & internal medicine ,Child ,ddc:618 ,Intensive care unit ,Coronavirus ,SARS-CoV-2 ,child ,treatment ,intensive care ,Intensive Care Units ,N/A ,Child, Preschool ,Female ,Europe / epidemiology ,Coronavirus Infections ,Human ,Cohort study ,medicine.medical_specialty ,Pneumonia, Viral / epidemiology ,Intensive Care Unit ,Pneumonia, Viral ,Patient Admission / trends ,Intensive Care Units / organization & administration ,Article ,Follow-Up Studie ,03 medical and health sciences ,Betacoronavirus ,030225 pediatrics ,Internal medicine ,Lower respiratory tract infection ,medicine ,Extracorporeal membrane oxygenation ,Humans ,Pediatrics, Perinatology, and Child Health ,Pandemics ,Pneumonia, Viral / therapy ,Mechanical ventilation ,Betacoronaviru ,Coronavirus Infection ,business.industry ,Risk Factor ,Infant, Newborn ,Infant ,Odds ratio ,medicine.disease ,ptbnet COVID-19 Study Group ,Clinical research ,El Niño ,Pediatrics, Perinatology and Child Health ,business ,Delivery of Health Care ,Follow-Up Studies - Abstract
Background To date, few data on paediatric COVID-19 have been published, and most reports originate from China. This study aimed to capture key data on children and adolescents with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection across Europe to inform physicians and health-care service planning during the ongoing pandemic. Methods This multicentre cohort study involved 82 participating health-care institutions across 25 European countries, using a well established research network—the Paediatric Tuberculosis Network European Trials Group (ptbnet)—that mainly comprises paediatric infectious diseases specialists and paediatric pulmonologists. We included all individuals aged 18 years or younger with confirmed SARS-CoV-2 infection, detected at any anatomical site by RT-PCR, between April 1 and April 24, 2020, during the initial peak of the European COVID-19 pandemic. We explored factors associated with need for intensive care unit (ICU) admission and initiation of drug treatment for COVID-19 using univariable analysis, and applied multivariable logistic regression with backwards stepwise analysis to further explore those factors significantly associated with ICU admission. Findings 582 individuals with PCR-confirmed SARS-CoV-2 infection were included, with a median age of 5·0 years (IQR 0·5–12·0) and a sex ratio of 1·15 males per female. 145 (25%) had pre-existing medical conditions. 363 (62%) individuals were admitted to hospital. 48 (8%) individuals required ICU admission, 25 (4%) mechanical ventilation (median duration 7 days, IQR 2–11, range 1–34), 19 (3%) inotropic support, and one ( Interpretation COVID-19 is generally a mild disease in children, including infants. However, a small proportion develop severe disease requiring ICU admission and prolonged ventilation, although fatal outcome is overall rare. The data also reflect the current uncertainties regarding specific treatment options, highlighting that additional data on antiviral and immunomodulatory drugs are urgently needed. Funding ptbnet is supported by Deutsche Gesellschaft für Internationale Zusammenarbeit.
- Published
- 2020
13. Rubella Virus Infected Macrophages and Neutrophils Define Patterns of Granulomatous Inflammation in Inborn and Acquired Errors of Immunity
- Author
-
Ludmila Perelygina, Raeesa Faisthalab, Emily Abernathy, Min-hsin Chen, LiJuan Hao, Lionel Bercovitch, Diana K. Bayer, Lenora M. Noroski, Michael T. Lam, Maria Pia Cicalese, Waleed Al-Herz, Arti Nanda, Joud Hajjar, Koen Vanden Driessche, Shari Schroven, Julie Leysen, Misha Rosenbach, Philipp Peters, Johannes Raedler, Michael H. Albert, Roshini S. Abraham, Hemalatha G. Rangarjan, David Buchbinder, Lisa Kobrynski, Anne Pham-Huy, Julie Dhossche, Charlotte Cunningham Rundles, Anna K. Meyer, Amy Theos, T. Prescott Atkinson, Amy Musiek, Mehdi Adeli, Ute Derichs, Christoph Walz, Renate Krüger, Horst von Bernuth, Christoph Klein, Joseph Icenogle, Fabian Hauck, Kathleen E. Sullivan, Perelygina, L., Faisthalab, R., Abernathy, E., Chen, M. -H., Hao, L., Bercovitch, L., Bayer, D. K., Noroski, L. M., Lam, M. T., Cicalese, M. P., Al-Herz, W., Nanda, A., Hajjar, J., Vanden Driessche, K., Schroven, S., Leysen, J., Rosenbach, M., Peters, P., Raedler, J., Albert, M. H., Abraham, R. S., Rangarjan, H. G., Buchbinder, D., Kobrynski, L., Pham-Huy, A., Dhossche, J., Cunningham Rundles, C., Meyer, A. K., Theos, A., Atkinson, T. P., Musiek, A., Adeli, M., Derichs, U., Walz, C., Kruger, R., von Bernuth, H., Klein, C., Icenogle, J., Hauck, F., and Sullivan, K. E.
- Subjects
Male ,inborn errors of immunity ,Neutrophils ,Immunology ,skin lesion ,primary immunodeficiency ,Cohort Studies ,Th2 Cells ,neutrophils ,granulomatous inflammation ,granuloma treatments ,Humans ,Immunology and Allergy ,Antigens, Viral ,Rubella ,Aged ,Original Research ,Inflammation ,Granuloma ,Tumor Necrosis Factor-alpha ,Macrophages ,Genetic Diseases, Inborn ,Hematopoietic Stem Cell Transplantation ,Immunologic Deficiency Syndromes ,Receptors, Interleukin-1 ,RC581-607 ,Middle Aged ,Immunohistochemistry ,macrophages ,vaccine-derived rubella viruses ,Cytokines ,Female ,Human medicine ,Disease Susceptibility ,Immunologic diseases. Allergy ,Rubella virus - Abstract
Rubella virus (RuV) has recently been found in association with granulomatous inflammation of the skin and several internal organs in patients with inborn errors of immunity (IEI). The cellular tropism and molecular mechanisms of RuV persistence and pathogenesis in select immunocompromised hosts are not clear. We provide clinical, immunological, virological, and histological data on a cohort of 28 patients with a broad spectrum of IEI and RuV-associated granulomas in skin and nine extracutaneous tissues to further delineate this relationship. Combined immunodeficiency was the most frequent diagnosis (67.8%) among patients. Patients with previously undocumented conditions, i.e., humoral immunodeficiencies, a secondary immunodeficiency, and a defect of innate immunity were identified as being susceptible to RuV-associated granulomas. Hematopoietic cell transplantation was the most successful treatment in this case series resulting in granuloma resolution; steroids, and TNF-α and IL-1R inhibitors were moderately effective. In addition to M2 macrophages, neutrophils were identified by immunohistochemical analysis as a novel cell type infected with RuV. Four patterns of RuV-associated granulomatous inflammation were classified based on the structural organization of granulomas and identity and location of cell types harboring RuV antigen. Identification of conditions that increase susceptibility to RuV-associated granulomas combined with structural characterization of the granulomas may lead to a better understanding of the pathogenesis of RuV-associated granulomas and discover new targets for therapeutic interventions.
- Published
- 2021
14. A first case of Mixta calida bacteremia and meningitis in a 5-week old child.
- Author
-
Van Hees S, Keulemans S, Vanden Driessche K, Schoonjans AS, Goegebuer T, and Lemmens A
- Subjects
- Humans, Infant, Cefotaxime therapeutic use, Meningitis, Bacterial microbiology, Meningitis, Bacterial drug therapy, Meningitis, Bacterial diagnosis, Treatment Outcome, Gammaproteobacteria pathogenicity, Anti-Bacterial Agents therapeutic use, Bacteremia microbiology, Bacteremia drug therapy, Enterobacteriaceae Infections microbiology, Enterobacteriaceae Infections drug therapy, Enterobacteriaceae Infections diagnosis
- Abstract
Mixta calida , previously known as Pantoea calida , was initially isolated from powdered infant milk in 2010. It falls within the Erwiniaceae family (class: Enterobacterales). While Mixta calida was traditionally regarded as non-pathogenic, we now present a case of Mixta calida bacteraemia and meningitis in a 5-week-old child, successfully treated with cefotaxime. This case, in contrast to prior reports with potential contamination issues, is the first to offer compelling evidence of Mixta calida' s pathogenicity in humans.
- Published
- 2024
- Full Text
- View/download PDF
15. A Pediatric Case of Fusobacterium necrophorum Mastoiditis and Meningitis Case Report in a Healthy Child and Review of the Literature.
- Author
-
Feenstra E, Van Roest A, Boes J, Spiritus T, Kenis S, Duval ELIM, Vanden Bossche S, Vanden Driessche K, and Jorens PG
- Abstract
In infants and children, bacterial meningitis caused by anaerobic bacteria is rare. However, a serious infection with the anaerobe Fusobacterium necrophorum can occur in previously healthy children with a peak incidence in preschool children and in adolescents. As the clinical presentation can be very similar to meningitis caused by aerobic bacteria, one should consider Fusobacterium necrophorum as the causative agent when preceded by or associated with otitis media with purulent otorrhea or mastoiditis, in combination with minimal or no improvement on empiric antibiotic treatment. As this pathogen can be difficult to culture, anaerobic cultures should be obtained. Prompt treatment with a third-generation cephalosporin and metronidazole should be initiated once suspected or confirmed. Surgical source control is often necessary, but even with adequate and prompt treatment, the morbidity and mortality in children with a Fusobacterium necrophorum meningitis remains high. In this report, we describe a case of Fusobacterium necrophorum meningitis in a previously healthy child and review the available literature., Competing Interests: The authors declare that there are no conflicts of interest regarding the publication of this article. Moreover, the patient is sufficiently anonymized according to the ICMJE guidelines., (Copyright © 2024 Elizabeth Feenstra et al.)
- Published
- 2024
- Full Text
- View/download PDF
16. Disseminated Tuberculosis Mimicking as Crohn's Disease in a Paediatric Patient.
- Author
-
Feenstra E, Driesen Y, Moes N, Jouret N, and Vanden Driessche K
- Abstract
Tuberculosis is an important infectious disease for children worldwide. The clinical presentation of tuberculosis in children is diverse and, depending on the affected organs, it is often accompanied with nonspecific symptoms that can mimic other diseases. In this report, we present a case of disseminated tuberculosis in an 11-year-old boy with intestinal followed by pulmonary involvement. The diagnosis was delayed for several weeks due to the clinical picture which was mimicking Crohn's disease, the known difficulties in diagnostic tests and the improvement on meropenem. This case demonstrates the importance of a detailed microscopic examination of gastrointestinal biopsies and the tuberculostatic effect of meropenem which physicians should be aware of., Competing Interests: The authors declare that there are no conflicts of interest., (Copyright © 2023 Elizabeth Feenstra et al.)
- Published
- 2023
- Full Text
- View/download PDF
17. The burden and surveillance of RSV disease in young children in Belgium-expert opinion.
- Author
-
Raes M, Daelemans S, Cornette L, Moniotte S, Proesmans M, Schaballie H, Frère J, Vanden Driessche K, and Van Brusselen D
- Subjects
- Humans, Infant, Infant, Newborn, Belgium epidemiology, Bronchiolitis epidemiology, Bronchiolitis virology, Hospitalization, Respiratory Syncytial Virus, Human, Population Surveillance, Respiratory Syncytial Virus Infections epidemiology
- Abstract
Infections with respiratory syncytial virus (RSV) can cause severe disease. In young children, RSV is the most common cause of lower respiratory tract illness and life-threatening infections most commonly occur in the first years of life. In adults, elderly and immunocompromised people are most vulnerable. Recently there has been an acceleration in the development of candidate RSV vaccines, monoclonal antibodies and therapeutics which are expected to become available in Europe within the next 2-10 years. Understanding the true burden of childhood RSV disease will become very important to support public health authorities and policy makers in the assessment of new therapeutic opportunities against RSV disease. A systematic literature search was performed to map local data on the burden of RSV disease and to evaluate available RSV surveillance systems. A group of 9 paediatric infectious diseases specialists participated in an expert panel. The purpose of this meeting was to evaluate and map the burden associated with RSV infection in children, including patient pathways and the epidemiological patterns of virus circulation in Belgium. Sources of information on the burden of RSV disease in Belgium are very limited. For the outpatient setting, it is estimated that 5-10% of young patients seen in primary care are referred to the hospital. Around 3500 children between 0 and 12 months of age are hospitalized for RSV-bronchiolitis every year and represent the majority of all hospitalizations. The current Belgian RSV surveillance system was evaluated and found to be insufficient. Knowledge gaps are highlighted and future perspectives and priorities offered., Conclusion: The Belgian population-based RSV surveillance should be improved, and a hospital-led reporting system should be put in place to enable the evaluation of the true burden of RSV disease in Belgium and to improve disease management in the future., What Is Known: • RSV bronchiolitis is a very important cause of infant hospitalization. • The burden of disease in the community is poorly studied and underestimated., What Is New: • This expert opinion summarizes knowledge gaps and offers insights that allow improvement of local surveillance systems in order to establish a future-proof RSV surveillance system., (© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.)
- Published
- 2023
- Full Text
- View/download PDF
18. Infliximab for Paradoxical Reactions in Pediatric Central Nervous System Tuberculosis.
- Author
-
Abo YN, Curtis N, Osowicki J, Haeusler G, Purcell R, Kadambari S, De Wachter M, Vanden Driessche K, Dekeyzer S, Coleman L, Crawford N, Graham S, Marais B, and Gwee A
- Subjects
- Adrenal Cortex Hormones, Child, Humans, Infliximab adverse effects, Prospective Studies, Antitubercular Agents adverse effects, Tuberculosis, Central Nervous System drug therapy
- Abstract
Paradoxical reactions in central nervous system tuberculosis (CNS-TB) are associated with significant morbidity and mortality. We describe 4 HIV-uninfected children treated for CNS-TB with severe paradoxical reactions unresponsive to corticosteroids. All made recovery after treatment with infliximab, highlighting the safety and effectiveness of infliximab for this complication, and need for prospective trials., (© The Author(s) 2021. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.)
- Published
- 2021
- Full Text
- View/download PDF
19. Rubella Virus Infected Macrophages and Neutrophils Define Patterns of Granulomatous Inflammation in Inborn and Acquired Errors of Immunity.
- Author
-
Perelygina L, Faisthalab R, Abernathy E, Chen MH, Hao L, Bercovitch L, Bayer DK, Noroski LM, Lam MT, Cicalese MP, Al-Herz W, Nanda A, Hajjar J, Vanden Driessche K, Schroven S, Leysen J, Rosenbach M, Peters P, Raedler J, Albert MH, Abraham RS, Rangarjan HG, Buchbinder D, Kobrynski L, Pham-Huy A, Dhossche J, Cunningham Rundles C, Meyer AK, Theos A, Atkinson TP, Musiek A, Adeli M, Derichs U, Walz C, Krüger R, von Bernuth H, Klein C, Icenogle J, Hauck F, and Sullivan KE
- Subjects
- Aged, Antigens, Viral metabolism, Cohort Studies, Cytokines metabolism, Disease Susceptibility, Female, Genetic Diseases, Inborn, Hematopoietic Stem Cell Transplantation, Humans, Immunohistochemistry, Immunologic Deficiency Syndromes, Male, Middle Aged, Receptors, Interleukin-1 antagonists & inhibitors, Rubella complications, Th2 Cells immunology, Tumor Necrosis Factor-alpha antagonists & inhibitors, Granuloma immunology, Inflammation immunology, Macrophages immunology, Neutrophils immunology, Rubella immunology, Rubella virus physiology
- Abstract
Rubella virus (RuV) has recently been found in association with granulomatous inflammation of the skin and several internal organs in patients with inborn errors of immunity (IEI). The cellular tropism and molecular mechanisms of RuV persistence and pathogenesis in select immunocompromised hosts are not clear. We provide clinical, immunological, virological, and histological data on a cohort of 28 patients with a broad spectrum of IEI and RuV-associated granulomas in skin and nine extracutaneous tissues to further delineate this relationship. Combined immunodeficiency was the most frequent diagnosis (67.8%) among patients. Patients with previously undocumented conditions, i.e., humoral immunodeficiencies, a secondary immunodeficiency, and a defect of innate immunity were identified as being susceptible to RuV-associated granulomas. Hematopoietic cell transplantation was the most successful treatment in this case series resulting in granuloma resolution; steroids, and TNF-α and IL-1R inhibitors were moderately effective. In addition to M2 macrophages, neutrophils were identified by immunohistochemical analysis as a novel cell type infected with RuV. Four patterns of RuV-associated granulomatous inflammation were classified based on the structural organization of granulomas and identity and location of cell types harboring RuV antigen. Identification of conditions that increase susceptibility to RuV-associated granulomas combined with structural characterization of the granulomas may lead to a better understanding of the pathogenesis of RuV-associated granulomas and discover new targets for therapeutic interventions., Competing Interests: MA is employed by Sidra Medicine and Hamad Medical Corporation, Qatar. HB is employed by Labor Berlin GmbH, Germany. JH received grants from Immune Deficiency Foundation, the US immunodeficiency network, Chao-physician Scientist award, the Texas Medical Center Digestive Diseases Center and the Jeffrey Modell Foundation. JH received honorarium, consultation fees from Horizon, Pharming, Baxalta, CSL Behring, the National guard, and Al-Faisal University Hospital. TPA received consultation fees from Horizon, Pharming, CSL Behring. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Perelygina, Faisthalab, Abernathy, Chen, Hao, Bercovitch, Bayer, Noroski, Lam, Cicalese, Al-Herz, Nanda, Hajjar, Vanden Driessche, Schroven, Leysen, Rosenbach, Peters, Raedler, Albert, Abraham, Rangarjan, Buchbinder, Kobrynski, Pham-Huy, Dhossche, Cunningham Rundles, Meyer, Theos, Atkinson, Musiek, Adeli, Derichs, Walz, Krüger, von Bernuth, Klein, Icenogle, Hauck and Sullivan.)
- Published
- 2021
- Full Text
- View/download PDF
20. Quantifying superspreading for COVID-19 using Poisson mixture distributions.
- Author
-
Kremer C, Torneri A, Boesmans S, Meuwissen H, Verdonschot S, Vanden Driessche K, Althaus CL, Faes C, and Hens N
- Subjects
- COVID-19 epidemiology, Computer Simulation, Hong Kong epidemiology, Humans, India epidemiology, Poisson Distribution, Rwanda epidemiology, COVID-19 transmission, COVID-19 virology, Infectious Disease Transmission, Vertical statistics & numerical data, SARS-CoV-2
- Abstract
The number of secondary cases, i.e. the number of new infections generated by an infectious individual, is an important parameter for the control of infectious diseases. When individual variation in disease transmission is present, like for COVID-19, the distribution of the number of secondary cases is skewed and often modeled using a negative binomial distribution. However, this may not always be the best distribution to describe the underlying transmission process. We propose the use of three other offspring distributions to quantify heterogeneity in transmission, and we assess the possible bias in estimates of the mean and variance of this distribution when the data generating distribution is different from the one used for inference. We also analyze COVID-19 data from Hong Kong, India, and Rwanda, and quantify the proportion of cases responsible for 80% of transmission, [Formula: see text], while acknowledging the variation arising from the assumed offspring distribution. In a simulation study, we find that variance estimates may be biased when there is a substantial amount of heterogeneity, and that selection of the most accurate distribution from a set of distributions is important. In addition we find that the number of secondary cases for two of the three COVID-19 datasets is better described by a Poisson-lognormal distribution.
- Published
- 2021
- Full Text
- View/download PDF
21. Bronchiolitis in COVID-19 times: a nearly absent disease?
- Author
-
Van Brusselen D, De Troeyer K, Ter Haar E, Vander Auwera A, Poschet K, Van Nuijs S, Bael A, Stobbelaar K, Verhulst S, Van Herendael B, Willems P, Vermeulen M, De Man J, Bossuyt N, and Vanden Driessche K
- Subjects
- Belgium, Child, Humans, Pandemics, SARS-CoV-2, Bronchiolitis epidemiology, Bronchiolitis therapy, COVID-19, Respiratory Syncytial Virus Infections diagnosis, Respiratory Syncytial Virus Infections epidemiology
- Abstract
Stay-at-home orders, physical distancing, face masks and other non-pharmaceutical interventions (NPIs) do not only impact COVID-19, but also the dynamics of various other infectious diseases. Bronchiolitis is a clinically diagnosed viral infection of the lower respiratory tract, and causes a yearly seasonal wave of admissions in paediatric wards worldwide. We counted 92,5% less bronchiolitis hospitalisations in Antwerp before the expected end of the peak this year (of which only 1 RSV positive), as compared to the last 3 years. Furthermore, there was a >99% reduction in the number of registered RSV cases in Belgium.Conslusion: The 2020 winter bronchiolitis peak is hitherto nonexistent, but we fear a 'delayed' spring/summer bronchiolitis peak when most NPIs will be relaxed and pre-pandemic life restarts. What is known? • Bronchiolitis causes a yearly seasonal wave of admissions in paediatric departments worldwide. • Non-pharmaceutical interventions (NPIs) do not only impact COVID-19, but also the dynamics of various other infectious diseases. What is new? • The 2020 winter bronchiolitis peak is hitherto nonexistent. • A 'delayed' spring or summer bronchiolitis peak could happen when most NPIs will be relaxed and pre-pandemic life restarts.
- Published
- 2021
- Full Text
- View/download PDF
22. Face masks in the post-COVID-19 era: a silver lining for the damaged tuberculosis public health response?
- Author
-
Vanden Driessche K, Mahlobo PZ, Venter R, Caldwell J, Jennings K, Diacon AH, Cotton MF, de Groot R, Hens N, Marx FM, Warren RM, Mishra H, and Theron G
- Subjects
- COVID-19 epidemiology, COVID-19 transmission, COVID-19 virology, Communicable Disease Control instrumentation, Health Policy, Humans, Mycobacterium tuberculosis pathogenicity, SARS-CoV-2 pathogenicity, Social Stigma, Tuberculosis microbiology, Tuberculosis mortality, Tuberculosis transmission, COVID-19 prevention & control, Communicable Disease Control standards, Masks standards, Tuberculosis prevention & control
- Published
- 2021
- Full Text
- View/download PDF
23. Exposure to cough aerosols and development of pulmonary COVID-19.
- Author
-
Vanden Driessche K, Nestele J, Grouwels J, and Duval EL
- Subjects
- Betacoronavirus, COVID-19, Humans, Pandemics, SARS-CoV-2, Aerosols, Coronavirus Infections diagnosis, Coronavirus Infections etiology, Cough complications, Pneumonia, Viral diagnosis, Pneumonia, Viral etiology
- Abstract
We hypothesized that most patients with severe pulmonary COVID-19 were exposed to cough aerosols. Among patients that were almost 100% certain which person infected them, only 14 out of 38 overall, and 9 out of 25 hospitalized patients requiring supplemental oxygen, were infected by someone who coughed, which did not support our hypothesis. Talking, especially with a loud voice, could be an alternative source generating SARS-CoV-2 aerosols. Further research is needed to determine how SARS-CoV-2 spreads. Avoiding to talk when you are not wearing your mask and not talking with a loud voice, 'voice etiquette', could be other public health interventions worthwhile exploring.
- Published
- 2020
- Full Text
- View/download PDF
24. Mass masking as a way to contain COVID-19 and exit lockdown in low- and middle-income countries.
- Author
-
Siewe Fodjo JN, Pengpid S, Villela EFM, Van Thang V, Ahmed M, Ditekemena J, Crespo BV, Wanyenze RK, Dula J, Watanabe T, Delgado-Ratto C, Vanden Driessche K, Van den Bergh R, and Colebunders R
- Subjects
- Betacoronavirus, COVID-19, Developing Countries, Humans, Masks, SARS-CoV-2, Coronavirus, Coronavirus Infections epidemiology, Pandemics, Pneumonia, Viral epidemiology
- Abstract
In new guidelines published on June 5th 2020, the World Health Organization (WHO) recommends that in areas with ongoing COVID-19 community transmission, governments should encourage the general public to wear face masks in specific situations and settings as part of a comprehensive approach to suppress COVID-19 transmission. Recent online surveys in 206,729 persons residing in nine low- and middle-income countries showed that 32.7%-99.7% of respondents used face masks with significant differences across age groups and sexes. Targeted health promotion strategies and government support are required to increase mask use by the general population., (Copyright © 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
25. Contribution of QuantiFERON-TB Gold-in-Tube to the Diagnosis of Mycobacterium tuberculosis Infection in Young Children in a Low TB Prevalence Country.
- Author
-
Debulpaep S, Corbière V, Levy J, Schelstraete P, Vanden Driessche K, Mascart F, and Mouchet F
- Abstract
Introduction: Interferon Gamma Release Assay (IGRA) has proven to be a useful test to evaluate the immune response to Mycobacterium tuberculosis antigens in children over the age of 5 years as an alternative to tuberculin skin testing (TST). Much less is known about its performance in younger children, who are at higher risk for developing tuberculosis (TB) disease after exposure. We aimed to evaluate the accuracy of using IGRA in TB screening in this population. Methods: Children below the age of 5 years at high risk for TB infection were prospectively enrolled, to compare the performance of TST and the QuantiFERON-TB Gold-In-Tube test (QFT). Children were treated in accordance with the diagnosis made at baseline and followed-up for 12 months. Results: We included a total of 60 children of which 97 blood samples were available for analysis. There was 90.72% agreement between TST and QFT (Kappa test 0.59, moderate agreement). With TST as a reference, the QFT positive predictive value was 0.72 and the negative predictive value 0.93. Discordant results were observed with 6% TST+/QFT- paired tests. When we restricted the comparison of TST and QFT to non-BCG-vaccinated children, the degree of agreement was more substantial (95%, Kappa test 0.75) and the negative predictive value was 0.99. We observed 3% discordant TST-/QFT+ results. All children with active TB disease had concordant positive QFT results, with QFT values above 4.00 IU/ml. Conclusion: In a low TB prevalence country, serial testing of QFT was found to produce a moderate agreement with TST results. False positive QFT results would have been eliminated by using a higher cutoff without misdiagnosing the children with TB disease. Some of the false negative QFT results could be explained by false positive TST results on consecutive testing. For now the most prudent approach would be to consider discordant QFT-/TST+ results as false negative QFT results, taking into account the young age of our population and the potential risk for evolution to active TB disease.
- Published
- 2019
- Full Text
- View/download PDF
26. Baylisascariasis: A young boy with neural larva migrans due to the emerging raccoon round worm.
- Author
-
Dunbar M, Lu S, Chin B, Huh L, Dobson S, Al-Rawahi GN, Morshed MG, and Vanden Driessche K
- Subjects
- Adolescent, Animals, Ascaridida Infections genetics, Ascaridoidea genetics, Ascaridoidea immunology, Central Nervous System Parasitic Infections diagnosis, Encephalitis genetics, Encephalitis pathology, Humans, Larva Migrans diagnosis, Larva Migrans genetics, Male, Nematode Infections genetics, North America, Ascaridida Infections pathology, Central Nervous System Parasitic Infections pathology, Larva Migrans pathology, Raccoons genetics
- Abstract
A 17-month-old boy from Vancouver, Canada, presented with a 5-day history of progressive somnolence, ataxia, and torticollis. Additional investigations revealed eosinophilic encephalitis with deep white matter changes on MR imaging. On day 13, serology came back positive for Baylisascaris procyonis antibodies. While prophylaxis after ingestion of soil or materials potentially contaminated with raccoon feces can prevent baylisascariasis, timely treatment can sometimes alter a disastrous outcome. Populations of infected raccoons are propagating globally, but cases of Baylisascaris neural larva migrans have so far only been reported from North America., Competing Interests: The authors declare no conflicts of interest.
- Published
- 2018
- Full Text
- View/download PDF
27. Bilateral subacute lacrimal gland enlargement mimicking dacryoadenitis in a 7-year-old boy: a rare adverse effect of valproic acid (sodium valproate).
- Author
-
Lyons C, Godoy F, and Vanden Driessche K
- Subjects
- Acute Disease, Child, Dacryocystitis diagnosis, Diagnosis, Differential, Drug Substitution, Ethosuximide therapeutic use, Humans, Lacrimal Apparatus Diseases diagnosis, Male, Submandibular Gland Diseases chemically induced, Submandibular Gland Diseases diagnosis, Anticonvulsants adverse effects, Dacryocystitis chemically induced, Lacrimal Apparatus Diseases chemically induced, Valproic Acid adverse effects
- Abstract
A healthy 7-year-old boy presented with bilateral symmetrical lacrimal gland enlargement; a week later salivary gland enlargement was also noted. Clinical investigations suggested no diagnosis, and surgical biopsy was considered. Valproic acid (sodium valproate), which he was taking for absence seizures, has been reported to cause salivary gland swelling in adults. Suspecting that a similar mechanism could be causal, the drug was discontinued. Complete resolution of the lacrimal and salivary gland enlargement rapidly ensued. This is the first report of lacrimal gland enlargement caused by valproic acid., (Copyright © 2017 American Association for Pediatric Ophthalmology and Strabismus. Published by Elsevier Inc. All rights reserved.)
- Published
- 2017
- Full Text
- View/download PDF
28. Surgical masks reduce airborne spread of Pseudomonas aeruginosa in colonized patients with cystic fibrosis.
- Author
-
Vanden Driessche K, Hens N, Tilley P, Quon BS, Chilvers MA, de Groot R, Cotton MF, Marais BJ, Speert DP, and Zlosnik JE
- Subjects
- Adolescent, Adult, Aged, Female, Humans, Male, Middle Aged, Pseudomonas Infections transmission, Young Adult, Cystic Fibrosis microbiology, Masks, Pseudomonas Infections prevention & control, Pseudomonas aeruginosa
- Published
- 2015
- Full Text
- View/download PDF
29. Effect of smoking history on outcome of patients diagnosed with TB and HIV.
- Author
-
Vanden Driessche K, Patel MR, Mbonze N, Tabala M, Yotebieng M, Behets F, and Van Rie A
- Subjects
- Adult, Democratic Republic of the Congo epidemiology, Female, Humans, Male, Proportional Hazards Models, Risk Factors, Time Factors, Treatment Outcome, Anti-Retroviral Agents administration & dosage, Anti-Retroviral Agents adverse effects, Antitubercular Agents administration & dosage, Antitubercular Agents adverse effects, HIV Infections complications, HIV Infections diagnosis, HIV Infections drug therapy, HIV Infections epidemiology, Smoking adverse effects, Smoking epidemiology, Smoking physiopathology, Tuberculosis, Pulmonary complications, Tuberculosis, Pulmonary diagnosis, Tuberculosis, Pulmonary drug therapy, Tuberculosis, Pulmonary mortality
- Published
- 2015
- Full Text
- View/download PDF
30. Integration and task shifting for TB/HIV care and treatment in highly resource-scarce settings: one size may not fit all.
- Author
-
Van Rie A, Patel MR, Nana M, Vanden Driessche K, Tabala M, Yotebieng M, and Behets F
- Subjects
- Adult, CD4 Lymphocyte Count, Cohort Studies, Democratic Republic of the Congo, Drug Utilization statistics & numerical data, Female, HIV Infections complications, Humans, Male, Middle Aged, Prospective Studies, Survival Analysis, Time Factors, Tuberculosis complications, Anti-Retroviral Agents therapeutic use, Antitubercular Agents therapeutic use, HIV Infections diagnosis, HIV Infections drug therapy, Primary Health Care methods, Tuberculosis diagnosis, Tuberculosis drug therapy
- Abstract
Background: A crucial question in managing HIV-infected patients with tuberculosis (TB) concerns when and how to initiate antiretroviral therapy (ART). The effectiveness of CD4-stratified ART initiation in a nurse-centered, integrated TB/HIV program at primary care in Kinshasa, Democratic Republic of Congo, was assessed., Methods: Prospective cohort study was conducted to assess the effect of CD4-stratified ART initiation by primary care nurses (513 TB patients, August 2007 to November 2009). ART was to be initiated at 1 month of TB treatment if CD4 count is <100 cells per cubic millimeter, at 2 months if CD4 count is 100-350 cells per cubic millimeter, and at the end of TB treatment after CD4 count reassessment if CD4 count is >350 cells per cubic millimeter. ART uptake and mortality were compared with a historical prospective cohort of 373 HIV-infected TB patients referred for ART to a centralized facility and 3577 HIV-negative TB patients (January 2006 to May 2007)., Results: ART uptake increased (17%-69%, P < 0.0001) and mortality during TB treatment decreased (20.1% vs 9.8%, P < 0.0003) after decentralized, nurse-initiated, CD4-stratified ART. Mortality among TB patients with CD4 count >100 cells per cubic millimeter was similar to that of HIV-negative TB patients (5.6% vs 6.3%, P = 0.65), but mortality among those with CD4 count <100 cells per cubic millimeter remained high (18.8%)., Conclusions: Nurse-centered, CD4-stratified ART initiation at primary care level was effective in increasing timely ART uptake and reducing mortality among TB patients but may not be adequate to prevent mortality among those presenting with severe immunosuppression. Further research is needed to determine the optimal management at primary care level of TB patients with CD4 counts <100 cells per cubic millimeter.
- Published
- 2014
- Full Text
- View/download PDF
31. Immune vulnerability of infants to tuberculosis.
- Author
-
Vanden Driessche K, Persson A, Marais BJ, Fink PJ, and Urdahl KB
- Subjects
- Adult, Age Factors, Antitubercular Agents pharmacology, Child, Disease Susceptibility, Humans, Immunologic Factors pharmacology, Immunologic Factors therapeutic use, Infant, Interferon-gamma biosynthesis, Interferon-gamma immunology, Interleukin-1 biosynthesis, Interleukin-1 immunology, Interleukin-12 biosynthesis, Interleukin-12 immunology, Mycobacterium tuberculosis drug effects, Mycobacterium tuberculosis pathogenicity, Tuberculosis drug therapy, Antitubercular Agents therapeutic use, Immunity, Innate, Mycobacterium tuberculosis immunology, Tuberculosis immunology, Tuberculosis physiopathology
- Abstract
One of the challenges faced by the infant immune system is learning to distinguish the myriad of foreign but nonthreatening antigens encountered from those expressed by true pathogens. This balance is reflected in the diminished production of proinflammatory cytokines by both innate and adaptive immune cells in the infant. A downside of this bias is that several factors critical for controlling Mycobacterium tuberculosis infection are significantly restricted in infants, including TNF, IL-1, and IL-12. Furthermore, infant T cells are inherently less capable of differentiating into IFN- γ -producing T cells. As a result, infected infants are 5-10 times more likely than adults to develop active tuberculosis (TB) and have higher rates of severe disseminated disease, including miliary TB and meningitis. Infant TB is a fundamentally different disease than TB in immune competent adults. Immunotherapeutics, therefore, should be specifically evaluated in infants before they are routinely employed to treat TB in this age group. Modalities aimed at reducing inflammation, which may be beneficial for adjunctive therapy of some forms of TB in older children and adults, may be of no benefit or even harmful in infants who manifest much less inflammatory disease.
- Published
- 2013
- Full Text
- View/download PDF
32. Training health care workers to promote HIV services for patients with tuberculosis in the Democratic Republic of Congo.
- Author
-
Vanden Driessche K, Sabue M, Dufour W, Behets F, and Van Rie A
- Abstract
Background: HIV counseling and testing, HIV prevention and provision of HIV care and support are essential activities to reduce the burden of HIV among patients with TB, and should be integrated into routine TB care., Methods: The development of training materials to promote HIV services for TB patients involved the definition of target health care workers (HCWs); identification of required tasks, skills and knowledge; review of international guidelines; and adaptation of existing training materials for voluntary counseling and testing, prevention of mother-to-child transmission of HIV, and management of opportunistic infections (OIs). Training effectiveness was assessed by means of questionnaires administered pre- and post-training, by correlating post-training results of HCWs with the centre's HIV testing acceptance rates, and through participatory observations at the time of on-site supervisory visits and monthly meetings., Results: Pre-training assessment identified gaps in basic knowledge of HIV epidemiology, the link between TB and HIV, interpretation of CD4 counts, prevention and management of OIs, and occupational post-exposure prophylaxis (PEP). Opinions on patients' rights and confidentiality varied. Mean test results increased from 72% pre-training to 87% post-training (p<0.001). Important issues regarding HIV epidemiology and PEP remained poorly understood post-training. Mean post-training scores of clinic's HCWs were significantly correlated with the centre's HIV testing acceptance rates (p=0.01). On-site supervisory visits and monthly meetings promoted staff motivation, participatory problem solving and continuing education. Training was also used as an opportunity to improve patient-centred care and HCWs' communication skills., Conclusion: Many HCWs did not possess the knowledge or skills necessary to integrate HIV activities into routine care for patients with TB. A participatory approach resulted in training materials that fulfilled local needs.
- Published
- 2009
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.